Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs MARKSANS PHARMA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA MARKSANS PHARMA. LACTOSE INDIA/
MARKSANS PHARMA.
 
P/E (TTM) x 33.2 21.6 154.2% View Chart
P/BV x 4.3 4.0 109.5% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 LACTOSE INDIA   MARKSANS PHARMA.
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
MARKSANS PHARMA.
Mar-23
LACTOSE INDIA/
MARKSANS PHARMA.
5-Yr Chart
Click to enlarge
High Rs9674 129.5%   
Low Rs3939 101.4%   
Sales per share (Unadj.) Rs52.340.9 127.9%  
Earnings per share (Unadj.) Rs1.05.9 16.4%  
Cash flow per share (Unadj.) Rs4.77.0 66.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs32.238.5 83.7%  
Shares outstanding (eoy) m12.59453.16 2.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.4 93.7%   
Avg P/E ratio x70.69.7 731.0%  
P/CF ratio (eoy) x14.58.1 179.2%  
Price / Book Value ratio x2.11.5 143.3%  
Dividend payout %08.5 0.0%   
Avg Mkt Cap Rs m85425,631 3.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1222,394 5.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m65818,521 3.6%  
Other income Rs m7593 1.2%   
Total revenues Rs m66519,115 3.5%   
Gross profit Rs m1153,393 3.4%  
Depreciation Rs m47519 9.0%   
Interest Rs m6091 66.1%   
Profit before tax Rs m153,377 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3723 0.4%   
Profit after tax Rs m122,653 0.5%  
Gross profit margin %17.418.3 95.0%  
Effective tax rate %17.521.4 81.5%   
Net profit margin %1.814.3 12.8%  
BALANCE SHEET DATA
Current assets Rs m37516,997 2.2%   
Current liabilities Rs m2663,654 7.3%   
Net working cap to sales %16.672.0 23.1%  
Current ratio x1.44.7 30.3%  
Inventory Days Days466 798.8%  
Debtors Days Days69382 843.6%  
Net fixed assets Rs m6435,246 12.3%   
Share capital Rs m126453 27.8%   
"Free" reserves Rs m28016,998 1.6%   
Net worth Rs m40617,452 2.3%   
Long term debt Rs m3300-   
Total assets Rs m1,01822,242 4.6%  
Interest coverage x1.238.0 3.3%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.60.8 77.6%   
Return on assets %7.112.3 57.7%  
Return on equity %3.015.2 19.6%  
Return on capital %10.219.9 51.3%  
Exports to sales %00-   
Imports to sales %31.37.3 430.3%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2061,348 15.3%   
Fx inflow Rs m1046,491 1.6%   
Fx outflow Rs m2091,348 15.5%   
Net fx Rs m-1055,143 -2.0%   
CASH FLOW
From Operations Rs m812,374 3.4%  
From Investments Rs m-10-2,592 0.4%  
From Financial Activity Rs m-841,978 -4.2%  
Net Cashflow Rs m-131,760 -0.8%  

Share Holding

Indian Promoters % 53.7 43.9 122.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 20.3 3.1%  
FIIs % 0.0 15.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 56.2 82.5%  
Shareholders   16,088 237,377 6.8%  
Pledged promoter(s) holding % 26.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LACTOSE INDIA vs MARKSANS PHARMA.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LACTOSE INDIA vs MARKSANS PHARMA. Share Price Performance

Period LACTOSE INDIA MARKSANS PHARMA. S&P BSE HEALTHCARE
1-Day -1.83% 0.93% 1.18%
1-Month -2.41% -0.26% -0.75%
1-Year 226.47% 110.58% 61.82%
3-Year CAGR 73.96% 45.33% 18.16%
5-Year CAGR 33.74% 43.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the LACTOSE INDIA share price and the MARKSANS PHARMA. share price.

Moving on to shareholding structures...

The promoters of LACTOSE INDIA hold a 53.7% stake in the company. In case of MARKSANS PHARMA. the stake stands at 43.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LACTOSE INDIA and the shareholding pattern of MARKSANS PHARMA..

Finally, a word on dividends...

In the most recent financial year, LACTOSE INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MARKSANS PHARMA. paid Rs 0.5, and its dividend payout ratio stood at 8.5%.

You may visit here to review the dividend history of LACTOSE INDIA, and the dividend history of MARKSANS PHARMA..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.